Zainab Al Lawati*
Department of Surgery, Texas Tech University Health Sciences Centre El Paso, USAFulltext PDF
Introduction: Neurological disorders and SARS-CoV-2pandemic are two conditions with a recent well-documented association. There is emerging evidences that shows SARS-CoV-2infection can modify clinical spectrum of manifested neurological disorders. SARS-CoV-2also plays a crucial role in the development of future diseases as long-term consequences. Case Description: We report a case report of a healthy man who unfortunately sustained a stroke due to SARSCoV-2 resulting in left sided weakness, spasticity and apraxia. As he was making some progress in his reh abilitation course it was noted that he had motor and non-motor manifestations of Parkinson’s Disease (PD). He was given carbidopa-levodopa and patient reported better control over his rigidity. His orthostatic hypotension was managed with Midodrine. His rehabilitation goals were shifted to address both post stroke and Parkinson’s disease rehabilitation. Discussion: It is well known that SARS-CoV-2 in patients already diagnosed with neurodegenerative diseases carries higher risk for hospitalization and death. However, little is known regarding the vise versa. There have been case reports on the development of Parkinson’s Disease (PD) in people after contracting SARS-CoV-2.Multiple hypotheses came up explaining the possibility that will be further analyzed in this article. Rehabilitation goals changes as the complications post SARS-CoV-2evolve. Conclusion: SARS-CoV-2can accelerate motor and non-motor symptoms of Parkinson’s disease in addition to increased anxiety levels with severe complications on the quality of the life and mental health. The role of Physiatry is crucial identifying these changes and adjusting rehabilitation plans based on patient’s goals of care.
SARS-CoV-2; Parkinson’s Disease (PD); Magnetic Resonance Imaging (MRI)
Zainab Al Lawati (2021) Can SARS-CoV-2 Potentiates Early Parkinson’s Disease? Case Report. Int Case Rep Jour 1(4):1-4.